Vanda Pharmaceuticals
VNDA
#8015
Rank
C$0.49 B
Marketcap
C$8.20
Share price
-2.68%
Change (1 day)
32.22%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : C$0.41 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has C$0.41 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.53 B4.39%
2023-12-31C$0.51 B-18.71%
2022-12-31C$0.63 B14.85%
2021-12-31C$0.55 B17.64%
2020-12-31C$0.46 B15.02%
2019-12-31C$0.40 B16.28%
2018-12-31C$0.35 B94.43%
2017-12-31C$0.18 B-5.07%
2016-12-31C$0.18 B-4.37%
2015-12-31C$0.19 B31.84%
2014-12-31C$0.15 B8.57%
2013-12-31C$0.13 B15.89%
2012-12-31C$0.11 B-20.94%
2011-12-31C$0.15 B-23.5%
2010-12-31C$0.19 B-8.36%
2009-12-31C$0.21 B282.4%
2008-12-31C$56.48 M-33.52%
2007-12-31C$84.96 M128.98%
2006-12-31C$37.1 M2.31%
2005-12-31C$36.27 M85.72%
2004-12-31C$19.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$31.18 B 7,406.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.86 B 2,275.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$18.49 B 4,351.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$7.47 B 1,698.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$8.06 B 1,841.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$14.83 B 3,469.68%๐Ÿ‡บ๐Ÿ‡ธ USA